SCHEMBL14770715

SCHEMBL14770715

c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2ccc3oc4ccc(-c5cccc(-c6cccc(-n7c8ccccc8c8ccccc87)c6)n5)cc4c3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
PLA2G10 O15496 1/20 0.34
PTPRF P10586 3/20 0.33
PTPN2 P17706 3/20 0.33
PTPN1 P18031 3/20 0.33
PGR P06401 1/20 0.33
TSPO P30536 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
PRKDC P78527 1/20 0.33
GAA P10253 1/20 0.33
MEN1 O00255 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
PTGER4 P35408 1/20 0.32
PDE10A Q9Y233 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14770574 0.94 KDM4E (0.43) L3MBTL1KDM4EATMPTPRFPTPN2
SCHEMBL14867943 0.94 KMT2A (0.38) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL14770629 0.94 KDM4E (0.38) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL18560742 0.92 KDM4E (0.39) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL24303628 0.92 ATM (0.44) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL16482382 0.92 ATM (0.44) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL14733746 0.92 ATM (0.44) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL18265992 0.92 ATM (0.44) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL18265963 0.92 ATM (0.44) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL14867957 0.92 ATM (0.44) L3MBTL1KDM4EATMPLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L L3MBTL1 3163/4885KDM4E 1763/4885ATM 1105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.